Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CRDF Cardiff Oncology, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.30 -3.7% | $15.37 -0.2% |
| StockIQ Score | 54C- Moderate Risk: High | 35F Weak Risk: High |
| Technical | 81A- | 13F |
| Fundamental | 30F | 35F |
| Growth | 40D | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Cardiff Oncology (CRDF) outperforms Ascentage Pharma (AAPG) in stability and fundamentals, scoring 61 in technicals and 30 in fundamentals compared to AAPG’s 18 and 35. AAPG leads in growth with a score of 50 versus CRDF’s 40, while CRDF has a slightly higher valuation score of 50 to AAPG’s 38. CRDF’s overall "Moderate" rating also contrasts with AAPG’s "Weak" rating.
